Article Details
Retrieved on: 2022-06-04 17:18:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Patients with treatment-naïve chronic lymphocytic leukemia (CLL) who received treatment with acalabrutinib (Calquence) either as a single-agent or in ...
Article found on: www.cancernetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here